The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
The Role of Aspirin in Cardiovascular Prevention
Open accessAbstract
Aspirin is well recognized as an effective antiplatelet drug for secondary prevention in subjects at high risk of cardiovascular events. However, most patients receiving long-term aspirin therapy still remain at substantial risk of thrombotic events due to insufficient inhibition of platelets, specifically via the thromboxane A2 pathway. Although the exact prevalence is unknown, estimates suggest that between 5.5% and 60% of patients using this drug may exhibit a degree of "aspirin resistance," depending upon the definition used and parameters measured. To date, only a limited number of clinical studies have convincingly investigated the importance of aspirin resistance. Of these, few are of a sufficient scale, well designed, and prospective, with aspirin used at standard doses. Also, most studies do not sufficiently address the issue of noncompliance to aspirin as a frequent, yet easily preventable cause of resistance to this antiplatelet drug. This review article provides a comprehensive overview of aspirin resistance, discussing its definition, prevalence, diagnosis, and therapeutic approaches. Moreover, the clinical implications of aspirin resistance are explored in various cardiovascular disease states, including diabetes mellitus, hypertension, heart failure, and other similar disorders where platelet reactivity is enhanced.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm
Lip, G. Y. H., Wrigley, B., & Pisters, R. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003333 · Cited by 32
Self-citationRetractedInhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs
VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231232a0 · Cited by 8,605
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470
Hansson, L., Zanchetti, A., Carruthers, S. G., Dahlöf, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K. H., Wedel, H., & Westerling, S. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04311-6 · Cited by 5,728
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Steinhubl, S. R., Berger, P. B., Mann III, J. T., Fry, E. T. A., DeLago, A., Wilmer, C., Topol, E. J., & for the CREDO Investigators (2002) · JAMA · doi:10.1001/jama.288.19.2411 · Cited by 3,078
Sleight, R. B., Sleight, P., Parish, S., Appleby, P. N., Collins, R., & Baigent, C. (1988) · PubMed · Cited by 2,868
Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events
Bhatt, D. L., Fox, K. A. A., Hacke, W., Berger, P. B., Black, H. R., Boden, W. E., Cacoub, P., Cohen, E. A., Creager, M. A., Easton, J. D., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060989 · Cited by 2,837
Mehta, S. R., Yusuf, S., Peters, R. J., Bertrand, M. E., Lewis, B. S., Natarajan, M. K., Malmberg, K., Rupprecht, H.-J., Zhao, F., Chrolavicius, S., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05701-4 · Cited by 2,809
急性心筋梗塞の疑いのある17187症例におけるストレプトキナーゼ静脈内投与,アスピリン経口投与,上記2つの併用または無処置の無作偽試験 ISIS-2
Dienstl, F., Backer, G. D., Cairns, J., Pedersen, F., Kala, R., Boissel, J., Schroeder, R., Horgan, J., & Tognoni, G. (1988) · The Lancet · Cited by 2,754
Mehta, S. R., Yusuf, S., & Peters, R. J. G. (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)00559-7 · Cited by 2,578
Diener, H.-C., Bogousslavsky, J., Brass, L. M., Cimminiello, C., Csiba, L., Kaste, M., Leys, D., Matias-Guiu, J., & Rupprecht, H.-J. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16721-4 · Cited by 2,275
A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women
Ridker, P. M., Cook, N. R., Lee, I.-M., Gordon, D., Gaziano, J. M., Manson, J. E., Hennekens, C. H., & Buring, J. E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050613 · Cited by 1,945
(2005) · The Lancet · doi:10.1016/s0140-6736(05)67660-x · Cited by 1,858
Prevalence and Correlates of Accelerated Atherosclerosis in Systemic Lupus Erythematosus
Roman, M. J., Shanker, B.-A., Davis, A., Lockshin, M. D., Sammaritano, L., Simantov, R., Crow, M. K., Schwartz, J. E., Paget, S. A., Devereux, R. B., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035471 · Cited by 1,427
Randomised trial of prophylactic daily aspirin in British male doctors
Peto, R., Gray, R., Collins, R., Wheatley, K., Hennekens, C., Jamrozik, K., Warlow, C., Hafner, B., Thompson, E., Norton, S., et al. (1988) · BMJ · doi:10.1136/bmj.296.6618.313 · Cited by 1,166
The way I see it: House officers need formal career development
Connor, A. (2002) · BMJ · doi:10.1136/bmj.324.7336.s71 · Cited by 1,143
Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus
Buse, J. B., Ginsberg, H. N., Bakris, G. L., Clark, N. G., Costa, F., Eckel, R., Fonseca, V., Gerstein, H. C., Grundy, S., Nesto, R. W., et al. (2007) · Diabetes Care · doi:10.2337/dc07-9917 · Cited by 1,055
Eikelboom, J. W., Hirsh, J., Weitz, J. I., Johnston, M., Yi, Q., & Yusuf, S. (2002) · Circulation · doi:10.1161/01.cir.0000013777.21160.07 · Cited by 1,053
Gum, P. A., Kottke-Marchant, K., Welsh, P. A., White, J., & Topol, E. J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)03014-0 · Cited by 1,022
Roncaglioni, M. C. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03539-x · Cited by 999
Maradit‐Kremers, H., Crowson, C. S., Nicola, P. J., Ballman, K. V., Roger, V. L., Jacobsen, S. J., & Gabriel, S. E. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20853 · Cited by 927
Profile and prevalence of aspirin resistance in patients with cardiovascular disease
Gum, P. A., Kottke-Marchant, K., Poggio, E. D., Gurm, H., Welsh, P. A., Brooks, L., Sapp, S. K., & Topol, E. J. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01631-9 · Cited by 820
Bhatt, D. L., Flather, M. D., Hacke, W., Berger, P. B., Black, H. R., Boden, W. E., Cacoub, P., Cohen, E. A., Creager, M. A., Easton, J. D., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.03.025 · Cited by 805
Berger, J. S., Roncaglioni, M. C., Avanzini, F., Pangrazzi, I., Tognoni, G., & Brown, D. L. (2006) · JAMA · doi:10.1001/jama.295.3.306 · Cited by 789
Markus, H. S., Droste, D. W., Kaps, M., Larrue, V., Lees, K. R., Siebler, M., & Ringelstein, E. B. (2005) · Circulation · doi:10.1161/01.cir.0000163561.90680.1c · Cited by 754
Biondi-Zoccai, G. G. L., Lotrionte, M., Agostoni, P., Abbate, A., Fusaro, M., Burzotta, F., Testa, L., Sheiban, I., & Sangiorgi, G. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl334 · Cited by 733
Buse, J. B., Ginsberg, H. N., Bakris, G. L., Clark, N. G., Costa, F., Eckel, R., Fonseca, V., Gerstein, H. C., Grundy, S., Nesto, R. W., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.179294 · Cited by 638
Modulation of Oxidant Stress In Vivo in Chronic Cigarette Smokers
Reilly, M., Delanty, N., Lawson, J. A., & FitzGerald, G. A. (1996) · Circulation · doi:10.1161/01.cir.94.1.19 · Cited by 612
Hankey, G. J., & Eikelboom, J. W. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68040-9 · Cited by 505
Platelet activation in type 2 diabetes mellitus
Ferroni, P., Basili, S., Falco, A., & Davì, G. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00836.x · Cited by 493
Aspirin and Clopidogrel Drug Response in Patients Undergoing Percutaneous Coronary Intervention
Lev, E. I., Patel, R. T., Maresh, K. J., Guthikonda, S., Granada, J., DeLao, T., Bray, P. F., & Kleiman, N. S. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.058 · Cited by 446
Aspirin Dose for the Prevention of Cardiovascular Disease: A Systematic Review
Campbell, C. L., Smyth, S., Montalescot, G., & Steinhubl, S. R. (2007) · JAMA · doi:10.1001/jama.297.18.2018 · Cited by 444
Snoep, J. D., Hovens, M. M. C., Eikenboom, J. C. J., van der Bom, J. G., Jukema, J. W., & Huisman, M. V. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.04.014 · Cited by 427
Cleland, J. G. F., Findlay, I., Jafri, S., Sutton, G., Falk, R., Bulpitt, C., Prentice, C., Ford, I., Trainer, A., & Poole-Wilson, P. A. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.03.010 · Cited by 407
Sacco, M., Pellegrini, F., Roncaglioni, M. C., Avanzini, F., Tognoni, G., Nicolucci, A., & on behalf of the PPP Collaborative Group (2003) · Diabetes Care · doi:10.2337/diacare.26.12.3264 · Cited by 381
In Vivo Formation of 8-Epi-Prostaglandin F2αIs Increased in Hypercholesterolemia
Davi, G., Alessandrini, P., Mezzetti, A., Minotti, G., Bucciarelli, T., Costantini, F., Cipollone, F., Bon, G. B., Ciabattoni, G., & Patrono, C. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.11.3230 · Cited by 350
Sex Differences in Platelet Reactivity and Response to Low-Dose Aspirin Therapy
Becker, D. M., Segal, J., Vaidya, D., Yanek, L. R., Herrera-Galeano, J. E., Bray, P. F., Moy, T. F., Becker, L. C., & Faraday, N. (2006) · JAMA · doi:10.1001/jama.295.12.1420 · Cited by 332
Aspirin and clopidogrel resistance: an emerging clinical entity
Wang, T. H., Bhatt, D. L., & Topol, E. J. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi684 · Cited by 309
Frelinger, A. L., Furman, M. I., Linden, M. D., Li, Y., Fox, M. L., Barnard, M. R., & Michelson, A. D. (2006) · Circulation · doi:10.1161/circulationaha.105.596627 · Cited by 307
Mueller, M. R., Salat, A., Stangl, P., Murabito, M., Pulaki, S., Boehm, D., Koppensteiner, R., Ergun, E., Mittlboeck, M., Schreiner, W., et al. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657677 · Cited by 299
Zimmermann, N., Wenk, A., Kim, U., Kienzle, P., Weber, A.-A., Gams, E., Schrör, K., & Hohlfeld, T. (2003) · Circulation · doi:10.1161/01.cir.0000081770.51929.5a · Cited by 287
Coronary Stent Restenosis in Patients Treated With Cilostazol
Douglas, J. S., Holmes, D. R., Kereiakes, D. J., Grines, C. L., Block, E., Ghazzal, Z. M. B., Morris, D. C., Liberman, H., Parker, K., Jurkovitz, C., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.530097 · Cited by 281
Prevalence of persistent platelet reactivity despite use of aspirin: A systematic review
Hovens, M. M. C., Snoep, J. D., Eikenboom, J. C. J., van der Bom, J. G., Mertens, B. J. A., & Huisman, M. V. (2007) · American Heart Journal · doi:10.1016/j.ahj.2006.10.040 · Cited by 269
An Update on Aspirin in the Primary Prevention of Cardiovascular Disease
Eidelman, R. S., Hebert, P. R., Weisman, S. M., & Hennekens, C. H. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.17.2006 · Cited by 253
Reticulated platelets and uninhibited COX‐1 and COX‐2 decrease the antiplatelet effects of aspirin
GUTHIKONDA, S., LEV, E. I., PATEL, R., DELAO, T., BERGERON, A. L., DONG, J. ‐., & KLEIMAN, N. S. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02387.x · Cited by 245
Efficacy of Antithrombotic Therapy in Chronic Heart Failure: The HELAS Study
Cokkinos, D. V., Haralabopoulos, G. C., Kostis, J. B., Toutouzas, P. K., & for the HELAS investigators (2006) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2006.02.012 · Cited by 217
Schwartz, K. A., Schwartz, D. E., Ghosheh, K., Reeves, M. J., Barber, K., & DeFranco, A. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.12.038 · Cited by 210
Macchi, L., Christiaens, L., Brabant, S., Sorel, N., Allal, J., Mauco, G., & Brizard, A. (2002) · Thrombosis Research · doi:10.1016/s0049-3848(02)00210-4 · Cited by 180
Resistance to antiplatelet drugs: molecular mechanisms and laboratory detection
CATTANEO, M. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02498.x · Cited by 179
Coronary Heart Disease in Patients With Diabetes
Berry, C., Tardif, J.-C., & Bourassa, M. G. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.09.046 · Cited by 168
Harrison, P., Segal, H., Blasbery, K., Furtado, C., Silver, L., & Rothwell, P. M. (2005) · Stroke · doi:10.1161/01.str.0000162719.11058.bd · Cited by 164
Narrative Review: Aspirin Resistance and Its Clinical Implications
Sanderson, S., Emery, J., Baglin, T., & Kinmonth, A.-L. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-5-200503010-00012 · Cited by 160
Cilostazol for peripheral arterial disease
Robless, P. A., Mikhailidis, D. P., & Stansby, G. P. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003748.pub3 · Cited by 153
Faraday, N. R., Yanek, L. R., Mathias, R. A., Herrera-Galeano, J. E., Vaidya, D. M., Moy, T. F., Fallin, M. D., Wilson, A. F., Bray, P. F., Becker, L. C., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.667584 · Cited by 153
Approaches to prevention of cardiovascular complications and events in diabetes mellitus
Coccheri, S. (2007) · Drugs · doi:10.2165/00003495-200767070-00005 · Cited by 139
Jakubowski, J. A., Matsushima, N., Asai, F., Naganuma, H., Brandt, J. T., Hirota, T., Freestone, S., & Winters, K. J. (2006) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02792.x · Cited by 128
Dipyridamole for preventing stroke and other vascular events in patients with vascular disease
de Schryver, E. L. L. M., Algra, A., & van Gijn, J. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001820.pub3 · Cited by 128
Ohmori, T., Yatomi, Y., NONAKA, T., Kobayashi, Y., Madoiwa, S., Mimuro, J., Ozaki, Y., & Sakata, Y. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01958.x · Cited by 121
Aspirin Resistance and Genetic Polymorphisms
Cambria-Kiely, J. A., & Gandhi, P. J. (2002) · Journal of Thrombosis and Thrombolysis · doi:10.1023/a:1022066305399 · Cited by 118
Pullicino, P. M., Thompson, J. L. P., BARTON, B. A., Levin, B. L., Graham, S., & Freudenberger, R. S. (2006) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2005.07.007 · Cited by 116
The fight against rheumatism: from willow bark to COX-1 sparing drugs.
Vane, J. R. (2000) · PubMed · Cited by 115
Elevated Platelet Microparticle Levels in Nonvalvular Atrial Fibrillation
Choudhury, A., Chung, I. K.-K., Blann, A. D., & Lip, G. Y. H. (2007) · CHEST Journal · doi:10.1378/chest.06-2039 · Cited by 111
Self-citationChoudhury, A., Chung, I. K.-K., Blann, A. D., & Lip, G. Y. H. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.038 · Cited by 108
Self-citationPrevalence of aspirin resistance in patients with type 2 diabetes
Fateh‐Moghadam, S., Plöckinger, U., Cabeza, N., Htun, P., Reuter, T., Ersel, S., Gawaz, M., Dietz, R., & Bocksch, W. (2005) · Acta Diabetologica · doi:10.1007/s00592-005-0186-y · Cited by 104
Aspirin and Clopidogrel Resistance
Michos, E. D., Ardehali, R., Blumenthal, R. S., Lange, R. A., & Ardehali, H. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.4.518 · Cited by 104
Borna, C., Lazarowski, E. R., van Heusden, C. A., Öhlin, H., & Erlinge, D. (2005) · Thrombosis Journal · doi:10.1186/1477-9560-3-10 · Cited by 102
Massie, B. M., Krol, W. F., Ammon, S. E., Armstrong, P. W., Cleland, J. G. F., Collins, J. F., Ezekowitz, M. D., Jafri, S. M., O’Connor, C. M., Packer, M., et al. (2004) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2004.02.006 · Cited by 101
Polidori, M. C., Praticò, D., Savino, K., Rokach, J., Stahl, W., & Mecocci, P. (2004) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2003.11.004 · Cited by 100
White, M., Ducharme, A., Ibrahim, R., Whittom, L., Lavoie, J., Guertin, M., Racine, N., He, Y., Yao, G., Rouleau, J. L., et al. (2006) · Clinical Science · doi:10.1042/cs20050317 · Cited by 100
Sane, D. C., McKee, S., Malinin, A. I., & Serebruany, V. L. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02718-2 · Cited by 95
Fischer, L., Schlienger, R. G., Matter, C. M., Jick, H., & Meier, C. R. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.22.2472 · Cited by 86
Serebruany, V. L., Malinin, A. I., Jerome, S. D., Lowry, D. R., Morgan, A., Sane, D. C., Tanguay, J., Steinhubl, S. R., & O’Connor, C. M. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00260-6 · Cited by 81
Parsing an enigma: the pharmacodynamics of aspirin resistance
FitzGerald, G. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12560-3 · Cited by 80
Wang, T. H., Bhatt, D. L., Fox, K. A. A., Steinhubl, S. R., Brennan, D. M., Hacke, W., Mak, K.-H., Pearson, T. A., Boden, W. E., Steg, P. G., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm274 · Cited by 77
Cho, J. Y. (2007) · Archives of Pharmacal Research · doi:10.1007/bf02977780 · Cited by 73
Pamukçu, B., Oflaz, H., & Nişancí, Y. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.10.007 · Cited by 73
Antiplatelet agents and anticoagulants for hypertension
Lip, G. Y. H., Felmeden, D. C., & Dwivedi, G. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003186.pub3 · Cited by 66
Self-citationAspirin Resistance: Definitions, Mechanisms, Prevalence, and Clinical Significance
Macchi, L., Sorel, N., & Christiaens, L. P. (2005) · Current Pharmaceutical Design · doi:10.2174/138161206775193064 · Cited by 65
Terms and Conditions: Semantic Complexity and Aspirin Resistance
Hennekens, C. H., Schrör, K., Weisman, S. M., & FitzGerald, G. A. (2004) · Circulation · doi:10.1161/01.cir.0000142056.69970.db · Cited by 63
Totani, L., Rotondo, S., Lorenzet, R., Tognoni, G., Berardis, G. D., Nicolucci, A., & Evangelista, V. (2004) · Thrombosis and Haemostasis · doi:10.1160/th04-07-0453 · Cited by 58
Cilostazol for peripheral arterial disease
Robless, P. A., Mikhailidis, D. P., & Stansby, G. P. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003748.pub2 · Cited by 58
Eikelboom, J. W., Hankey, G. J., Thom, J., Claxton, A., Yi, Q., Gilmore, G., Staton, J. M., Barden, A. E., & Norman, P. E. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01640.x · Cited by 53
Chakraborty, K., Khan, G. A., Banerjee, P., Ray, U., & Sinha, A. K. (2003) · Platelets · doi:10.1080/095371032000158763 · Cited by 51
Prevalence of aspirin resistance in patients with an evolving acute myocardial infarction
Poulsen, T. S., Jørgensen, B., Korsholm, L., Licht, P. B., Haghfelt, T. H., & Mickley, H. (2006) · Thrombosis Research · doi:10.1016/j.thromres.2006.04.005 · Cited by 49
Louden, K. A., Pipkin, F. B., Heptinstall, S., et al. (1994) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1994.tb13110.x · Cited by 49
European stroke prevention study 2: Efficacy and safety data
Diener, H., FORBES, C., RIEKKINEN, P., Sivenius, J., Smets, P., & LOWENTHAL, A. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(97)86566-5 · Cited by 48
Fehér, G., Koltai, K., Papp, E., Alkonyi, B., Sólyom, A., Kenyeres, P., Késmárky, G., Czopf, L., & Tóth, K. (2006) · Drugs & Aging · doi:10.2165/00002512-200623070-00002 · Cited by 47
Multimedikation, Compliance und Zusatzmedikation bei Patienten mit kardiovaskulären Erkrankungen
Rottlaender, D., Scherner, M. P., Schneider, T., & Erdmann, E. (2007) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-2007-959300 · Cited by 45
Vaidyula, V. R., Bagga, S., Jalagadugula, G. S., Gaughan, J. P., Wilhite, D. B., Comerota, A. J., & Rao, A. K. (2006) · Thrombosis and Haemostasis · doi:10.1160/th06-08-0451 · Cited by 44
Changing aspirin use in patients with Type 2 diabetes in the UKPDS
Cull, C. A., Neil, H. A. W., & Holman, R. R. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01328.x · Cited by 43
Effect of aspirin on constitutive nitric oxide synthase and the biovailability of NO
Madajka, M., Korda, M. M., WHITE, J. E., et al. (2003) · Thrombosis Research · doi:10.1016/s0049-3848(03)00419-5 · Cited by 42
Aspirin Resistance: An Evaluation of Current Evidence and Measurement Methods
Martin, C. P., & Talbert, R. L. (2005) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.2005.25.7.942 · Cited by 39
Antiplatelet Agents for the Prevention of Cardiovascular Disease in Diabetes Mellitus
Colwell, J. A. (2004) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200404020-00003 · Cited by 32
Atherosclerosis and Systemic Lupus Erythematosus
Abusamieh, M., & Ash, J. Y. (2004) · Cardiology in Review · doi:10.1097/01.crd.0000124843.85660.ed · Cited by 29
Bruno, A., McConnell, J. P., Cohen, S. N., Tietjen, G. E., Wallis, R. A., Gorelick, P. B., & Bang, N. U. (2004) · Stroke · doi:10.1161/01.str.0000117097.76953.a6 · Cited by 29
Aspirin resistance: What, why and when?
Shantsila, E., Watson, T., & Lip, G. Y. H. (2006) · Thrombosis Research · doi:10.1016/j.thromres.2006.08.009 · Cited by 29
Self-citationAntiplatelet agents and anticoagulants for hypertension
Lip, G. Y. H., & Felmeden, D. C. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003186.pub2 · Cited by 19
Self-citationImpact of Nonsteroidal Antiinflammatory Drugs on the Cardioprotective Effects of Aspirin
Corman, S. L., Fedutes, B. A., & Ansani, N. T. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1e514 · Cited by 18
Aspirin Resistance: A Review Of Diagnostic Methodology, Mechanisms, and Clinical Utility
Schwartz, K. A. (2006) · Advances in clinical chemistry · doi:10.1016/s0065-2423(06)42003-5 · Cited by 14
Influence of anti-platelet drugs on platelet-vessel waif interacticnks
Pao, G. H. R. (1987) · Prostaglandins Leukotrienes and Medicine · doi:10.1016/0262-1746(87)90143-0 · Cited by 14
Kurth, T., Hennekens, C. H., Buring, J. E., & Gaziano, J. M. (2004) · Current Rheumatology Reports · doi:10.1007/s11926-004-0009-0 · Cited by 14
Cited by
Feldman, D., Pamboukian, S. V., Teuteberg, J. J., Birks, E., Lietz, K., Moore, S. A., Morgan, J. A., Arabia, F., Bauman, M. E., Buchholz, H. W., et al. (2013) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2012.09.013 · Cited by 1,368
Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors
Gasparyan, A. Y., Ayvazyan, L., Blackmore, H., & Kitas, G. D. (2011) · Rheumatology International · doi:10.1007/s00296-011-1999-3 · Cited by 694
Self-citationPlatelet receptors and signaling in the dynamics of thrombus formation
Rivera, J., Lozano, M. L., Navarro-Nunez, L., & Vicente, V. (2009) · Haematologica · doi:10.3324/haematol.2008.003178 · Cited by 416
Metadata
- Authors
- Gasparyan, A. Y., Watson, T., & Lip, G. Y. H.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2008-05
- Volume
- 51
- Issue
- 19
- Pages
- 1829-1843
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W42705460
- Cited by
- 263
- References
- 106
- FWCI
- 22.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.